An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels



Status:Not yet recruiting
Conditions:High Cholesterol
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Contact:Brian S Marino, DO
Email:brm9071@nyp.org
Phone:814-404-4169

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The investigators aim to test the hypothesis that dietary supplementation with VASCAZEN will
correct omega-3 deficiency in cardiac rehab patients and improve biochemical risk factors.


Inclusion Criteria:

- Adult subjects (> or = 18 years of age)

- Enrolled in Cardiac Rehabilitation clinic with documented cardiovascular disease as
assessed by the principle investigator

- Has had cardiovascular examination within the past 2 months

Exclusion Criteria:

- Subjects who refuse to provide written consent

- Subjects with medical conditions, as determined by the principal investigator, which
prevented them from study participation

- Subjects with a known bleeding or clotting disorder

- Subjects with known allergies to fish

- Subjects with an implantable cardiac defibrillator

- Subjects with a heart transplant

- Female subjects who are currently taking hormone replacement therapy

- Subjects who are pregnant or planning on becoming pregnant

- Subjects currently taking Omega-3 fatty acid supplements (either under medical
supervision or self-administered)
We found this trial at
1
site
The NYHQ Cardiac Health Center
Fresh Meadows, New York 11365
?
mi
from
Fresh Meadows, NY
Click here to add this to my saved trials